A detailed history of Certified Advisory Corp transactions in Stryker Corp stock. As of the latest transaction made, Certified Advisory Corp holds 703 shares of SYK stock, worth $246,956. This represents 0.03% of its overall portfolio holdings.

Number of Shares
703
Previous 893 21.28%
Holding current value
$246,956
Previous $319,000 25.08%
% of portfolio
0.03%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$324.3 - $354.67 $61,617 - $67,387
-190 Reduced 21.28%
703 $239,000
Q1 2024

May 10, 2024

BUY
$293.94 - $358.71 $3,233 - $3,945
11 Added 1.25%
893 $319,000
Q4 2023

Feb 09, 2024

BUY
$253.85 - $299.46 $4,315 - $5,090
17 Added 1.97%
882 $264,000
Q3 2023

Nov 13, 2023

BUY
$266.54 - $302.43 $18,657 - $21,170
70 Added 8.81%
865 $236,000
Q2 2023

Aug 14, 2023

SELL
$271.49 - $305.09 $134,387 - $151,019
-495 Reduced 38.37%
795 $242,000
Q1 2023

May 15, 2023

BUY
$246.13 - $285.47 $60,794 - $70,511
247 Added 23.68%
1,290 $368,000
Q4 2022

Feb 14, 2023

BUY
$205.51 - $253.93 $214,346 - $264,848
1,043 New
1,043 $254,000
Q2 2021

Aug 16, 2021

SELL
$242.95 - $267.0 $151,114 - $166,074
-622 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$221.01 - $248.82 $221 - $248
1 Added 0.16%
622 $152,000
Q2 2020

Jul 27, 2020

BUY
$144.67 - $207.03 $2,893 - $4,140
20 Added 3.33%
621 $112,000
Q3 2019

Nov 12, 2019

BUY
$205.4 - $221.82 $205 - $221
1 Added 0.17%
601 $130,000
Q1 2019

May 07, 2019

BUY
$152.46 - $198.0 $15,246 - $19,800
100 Added 20.0%
600 $119,000
Q4 2018

Feb 04, 2019

SELL
$145.0 - $178.65 $1,740 - $2,143
-12 Reduced 2.34%
500 $78,000
Q1 2018

Apr 30, 2018

BUY
$148.01 - $168.91 $74,005 - $84,455
500 Added 4166.67%
512 $82,000
Q4 2017

Feb 22, 2018

BUY
$143.51 - $159.74 $1,722 - $1,916
12
12 $1,000

Others Institutions Holding SYK

About STRYKER CORP


  • Ticker SYK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 378,320,992
  • Market Cap $133B
  • Description
  • Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...
More about SYK
Track This Portfolio

Track Certified Advisory Corp Portfolio

Follow Certified Advisory Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Certified Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Certified Advisory Corp with notifications on news.